CalcinosisSymptoms, Doctors, Treatments, Advances & More
Learn About Calcinosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Daniela Kroshinsky is a Dermatologist practicing medicine in Durham, North Carolina. She has been practicing medicine for over 23 years. Dr. Kroshinsky is rated as an Elite provider by MediFind in the treatment of Calcinosis. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Calciphylaxis, Cellulitis, Calcinosis, and Acute Febrile Neutrophilic Dermatosis. Dr. Kroshinsky is board certified in American Board Of Dermatology, Dermatology.
Massachusetts General Hospital-Renal Associates
Sagar Nigwekar is a Nephrologist practicing medicine in Boston, Massachusetts. Dr. Nigwekar is rated as an Elite provider by MediFind in the treatment of Calcinosis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Calciphylaxis, Calcinosis, Chronic Kidney Disease, Parathyroidectomy, and Kidney Transplant.
ASST Santi Paolo E Carlo
Mario Cozzolino practices practicing medicine in Milan, Italy. Mr. Cozzolino is rated as an Elite expert by MediFind in the treatment of Calcinosis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Calcinosis, Hyperparathyroidism, Malnutrition, Kidney Transplant, and Parathyroidectomy.
Summary: Calciphylaxis is a rare yet life-threatening condition involving pronounced calcification in small blood vessels of the skin. Knowledge about its underlying mechanisms and contributing risk factors remains limited. Chronic kidney disease is one of the strongest disease predictors. No evidence based effective therapy is currently available. Research on the topic is mainly hindered by the condition'...
Summary: The Swedish CArdioPulmonary bioImage Study (SCAPIS) is a unique, large-scale national research initiative involving 30,000 randomly selected individuals aged 50-64, recruited between 2014 and 2018. The study is a collaborative effort among six university hospitals across Sweden. A follow-up study, SCAPIS 2, is conducted for half of the original participants. In Stockholm, 2,500 individuals will be...